These results were comparable to those of studies showing that increasing of Nrf2 and anti-oxidant metabolites inhibited liver injury and inflammation.(19) Nrf2 and anti-oxidant metabolites in the liver may rescue the pathology of NASH and HCC development by feeding with STHD-01. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.